Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

[1]  T. Vesikari,et al.  Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Treanor,et al.  Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons , 2010, BMC infectious diseases.

[3]  René Ecochard,et al.  Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model , 2010, BMC medical research methodology.

[4]  H. Ehrlich,et al.  A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models , 2010, PloS one.

[5]  T. Vesikari,et al.  Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. , 2009, The Journal of infectious diseases.

[6]  B. Stricker,et al.  Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002. , 2009, Vaccine.

[7]  A. Monto,et al.  Comparative efficacy of inactivated and live attenuated influenza vaccines. , 2009, The New England journal of medicine.

[8]  U. Reichl,et al.  Continuous cell lines as a production system for influenza vaccines , 2009, Expert review of vaccines.

[9]  R. Bugarini,et al.  A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine. , 2009, Vaccine.

[10]  H. Ehrlich,et al.  A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. , 2009, The Journal of infectious diseases.

[11]  K. Reisinger,et al.  Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. , 2009, The Journal of infectious diseases.

[12]  R. Bugarini,et al.  Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. , 2009, The Journal of infectious diseases.

[13]  N. Cox,et al.  Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[14]  M. Howard,et al.  Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines , 2009, Expert review of vaccines.

[15]  R. Bugarini,et al.  Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial. , 2009, Vaccine.

[16]  J. Devaster,et al.  Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example , 2009, BMC infectious diseases.

[17]  R. Greenlee,et al.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. , 2009, The Journal of infectious diseases.

[18]  R. Couch.  Seasonal inactivated influenza virus vaccines. , 2008, Vaccine.

[19]  Ron A M Fouchier,et al.  Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. , 2008, Vaccine.

[20]  T. Cate,et al.  Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. , 2008, Vaccine.

[21]  H. Ehrlich,et al.  A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. , 2008, The New England journal of medicine.

[22]  B. Farham.  Aches and pains , 2008 .

[23]  A. Monto,et al.  Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. , 2006, The New England journal of medicine.

[24]  T. Cai,et al.  Joint Inferences on Vaccine Efficacy Against Infection and Disease with Application to the First HIV Vaccine Efficacy Trial , 2006, Journal of biopharmaceutical statistics.

[25]  G. Poland,et al.  Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults. , 2003, Vaccine.

[26]  A. Palache,et al.  Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. , 1997, The Journal of infectious diseases.

[27]  R. Webster,et al.  Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. , 1989, The Journal of infectious diseases.

[28]  A. I. McLeod,et al.  A Remark on Algorithm as 183. An Efficient and Portable Pseudo‐Random Number Generator , 1985 .

[29]  M Nurminen,et al.  Comparative analysis of two rates. , 1985, Statistics in medicine.

[30]  I. D. Hill,et al.  An Efficient and Portable Pseudo‐Random Number Generator , 1982 .

[31]  R. Jennrich,et al.  A Remark on Algorithm as 10 , 1971 .

[32]  L. Brammer,et al.  Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. , 2009, MMWR. Morbidity and mortality weekly report.

[33]  Sheri Fink,et al.  Aches and pains. Learning lessons from the influenza vaccine shortage. , 2004, IAVI report : newsletter on international AIDS vaccine research.

[34]  A. Osterhaus,et al.  Haemagglutination-inhibiting antibody to influenza virus. , 2003, Developments in biologicals.

[35]  C. Bridges,et al.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[36]  J. Wood,et al.  Comparison of influenza serological techniques by international collaborative study. , 1994, Vaccine.